Kirkland & Ellis advised Patient Square Capital, a dedicated health care investment firm, on its Series B investment in Kriya Therapeutics, Inc., a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. The $100 million financing round was led by Patient Square Capital and also included participation from new investors and existing institutional investors. The financing, which closed today, will support Kriya Therapeutic’s mission of transforming the design, development and manufacturing of gene therapies.